Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different PEG bowel preparation methods for colonoscopy quality and polyp detection
ChiCTR2000028861Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Dalian Medical University
- Start
- Feb 2020
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of macrogol in gastrointestinal conditions (3 arms), sponsored by The Second Affiliated Hospital of Dalian Medical University. Primary endpoints: Boston score, Polyp detection rate and 3 more. Planned start Feb 2020; status: not yet recruiting.
02
Drugs
macrogol
03
Conditions
gastrointestinal conditions
Beyond the preview
Go deeper on ChiCTR2000028861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000028861.